Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells

Hepatocellular carcinoma is the most common subtype of liver cancer. Protein arginine N-methyltransferase 1 was shown to be upregulated in various cancers. However, the role of protein arginine N-methyltransferase 1 in hepatocellular carcinoma progression remains incompletely understood. We investig...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing Gou, ShuJiao He, ZeJian Zhou
Format: Article
Language:English
Published: SAGE Publishing 2017-02-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317691419
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850052454292389888
author Qing Gou
ShuJiao He
ZeJian Zhou
author_facet Qing Gou
ShuJiao He
ZeJian Zhou
author_sort Qing Gou
collection DOAJ
description Hepatocellular carcinoma is the most common subtype of liver cancer. Protein arginine N-methyltransferase 1 was shown to be upregulated in various cancers. However, the role of protein arginine N-methyltransferase 1 in hepatocellular carcinoma progression remains incompletely understood. We investigated the clinical and functional significance of protein arginine N-methyltransferase 1 in a series of clinical hepatocellular carcinoma samples and a panel of hepatocellular carcinoma cell lines. We performed suppression analysis of protein arginine N-methyltransferase 1 using small interfering RNA to determine the biological roles of protein arginine N-methyltransferase 1 in hepatocellular carcinoma. In addition, the expression of epithelial-mesenchymal transition indicators was verified by western blotting in hepatocellular carcinoma cell lines after small interfering RNA treatment. Protein arginine N-methyltransferase 1 expression was found to be significantly upregulated in hepatocellular carcinoma cell lines and clinical tissues. Moreover, downregulation of protein arginine N-methyltransferase 1 in hepatocellular carcinoma cells by small interfering RNA could inhibit cell proliferation, migration, and invasion in vitro. These results indicate that protein arginine N-methyltransferase 1 may contribute to hepatocellular carcinoma progression and serves as a promising target for the treatment of hepatocellular carcinoma patients.
format Article
id doaj-art-4d01ff3c927641b2a58bbaddb783e41a
institution DOAJ
issn 1423-0380
language English
publishDate 2017-02-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-4d01ff3c927641b2a58bbaddb783e41a2025-08-20T02:52:48ZengSAGE PublishingTumor Biology1423-03802017-02-013910.1177/1010428317691419Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cellsQing Gou0ShuJiao He1ZeJian Zhou2Department of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, P.R. ChinaDepartment of Cancer Center, Chinese Medicine-Integrated Hospital, Guangzhou, P.R. ChinaDepartment of Interventional Radiology, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, P.R. ChinaHepatocellular carcinoma is the most common subtype of liver cancer. Protein arginine N-methyltransferase 1 was shown to be upregulated in various cancers. However, the role of protein arginine N-methyltransferase 1 in hepatocellular carcinoma progression remains incompletely understood. We investigated the clinical and functional significance of protein arginine N-methyltransferase 1 in a series of clinical hepatocellular carcinoma samples and a panel of hepatocellular carcinoma cell lines. We performed suppression analysis of protein arginine N-methyltransferase 1 using small interfering RNA to determine the biological roles of protein arginine N-methyltransferase 1 in hepatocellular carcinoma. In addition, the expression of epithelial-mesenchymal transition indicators was verified by western blotting in hepatocellular carcinoma cell lines after small interfering RNA treatment. Protein arginine N-methyltransferase 1 expression was found to be significantly upregulated in hepatocellular carcinoma cell lines and clinical tissues. Moreover, downregulation of protein arginine N-methyltransferase 1 in hepatocellular carcinoma cells by small interfering RNA could inhibit cell proliferation, migration, and invasion in vitro. These results indicate that protein arginine N-methyltransferase 1 may contribute to hepatocellular carcinoma progression and serves as a promising target for the treatment of hepatocellular carcinoma patients.https://doi.org/10.1177/1010428317691419
spellingShingle Qing Gou
ShuJiao He
ZeJian Zhou
Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
Tumor Biology
title Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
title_full Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
title_fullStr Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
title_full_unstemmed Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
title_short Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
title_sort protein arginine n methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells
url https://doi.org/10.1177/1010428317691419
work_keys_str_mv AT qinggou proteinargininenmethyltransferase1promotestheproliferationandmetastasisofhepatocellularcarcinomacells
AT shujiaohe proteinargininenmethyltransferase1promotestheproliferationandmetastasisofhepatocellularcarcinomacells
AT zejianzhou proteinargininenmethyltransferase1promotestheproliferationandmetastasisofhepatocellularcarcinomacells